Nonalcoholic Fatty Liver Disease [dsyn]    
Steatohepatitis [dsyn]    
CURRENT [tmco]    
Status [qlco]    
Nonalcoholic Fatty Liver Disease [dsyn]    
1980s [tmco]    
Now [tmco]    
ELEVATED LIVER ENZYMES [fndg]    
Chronic Liver Disease [dsyn]    
Western [spco]    
Countries [geoa]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Adults [aggp]    
Children [aggp]    
Epidemics [phpr]    
OBESITY [dsyn]    
DIABETES MELLITUS, TYPE II [dsyn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Often [tmco]    
sequelae [patf]    
METABOLIC SYNDROME [dsyn]    
Central Obesity [fndg]    
Type II Diabetes [dsyn]    
HYPERTENSION [dsyn]    
Hyperlipidaemia, NOS [dsyn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Spectrum [qnco]    
Liver Diseases [dsyn]    
Range [qnco]    
Simple [qlco]    
hepatic steatosis [dsyn]    
Predominant [qlco]    
Lobular [qlco]    
INFLAMMATION [patf]    
Centrilobular [spco]    
FIBROSIS [patf]    
Call [menp]    
Nonalcoholic Steatohepatitis [dsyn]    
progress [ftcn]    
CIRRHOSIS [dsyn]    
Decompensated liver disease [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
Natural History [ocdi]    
Defined [inpr]    
Observed [ftcn]    
progress [ftcn]    
CIRRHOSIS [dsyn]    
Affected [ftcn]    
INSULIN RESISTANCE [patf]    
Nearly [qlco]    
Thought [menp]    
Play [dora]    
Important [qlco]    
pathogenesis [ftcn]    
Leading [tmco]    
Lipid Metabolism [moft]    
INSULIN RESISTANCE [patf]    
Reported [inpr]    
General Population [popg]    
approaching [spco]    
Suggest [idcn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Important [qlco]    
Public Health [bmod]    
Concern [idcn]    
DATE [tmco]    
Proven [qlco]    
Difficult [qlco]    
Front [ftcn]    
Line [spco]    
therapy [ftcn]    
lifestyle Modification [socb]    
WEIGHTLOSS [fndg]    
Decreased [qnco]    
Caloric Intake [qnco]    
Moderate Exercise [dora]    
Patients [podg]    
Often [tmco]    
Difficult [qlco]    
Maintain [acty]    
Long Term [tmco]    
GIVEN [cnce]    
INSULIN RESISTANCE [patf]    
Plays [dora]    
Dominant [ftcn]    
pathogenesis [ftcn]    
Examined [fndg]    
Glucagon-like Peptide-1 Receptor Agonist [phsu]    
overview [inpr]    
INSULIN RESISTANCE [patf]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Detailed [qlco]    
summary [inpr]    
Clinical Data [inpr]    
